» Articles » PMID: 37060186

Lactate-induced Protein Lactylation: A Bridge Between Epigenetics and Metabolic Reprogramming in Cancer

Overview
Journal Cell Prolif
Date 2023 Apr 15
PMID 37060186
Authors
Affiliations
Soon will be listed here.
Abstract

Lactate is not only an endpoint of glycolysis but is gradually being discovered to play the role of a universal metabolic fuel for energy via the 'lactate shuttle' moving between cells and transmitting signals. The glycolytic-dependent metabolism found in tumours and fast-growing cells has made lactate a pivotal player in energy metabolism reprogramming, which enables cells to obtain abundant energy in a short time. Moreover, lactate can provide favourable conditions for tumorigenesis by shaping the acidic tumour microenvironment, recruiting immune cells, etc. and the recently discovered lactate-induced lactylation moves even further on pro-tumorigenesis mechanisms of lactate production, circulation and utilization. As with other epigenetic modifications, lactylation can modify histone proteins to alter the spatial configuration of chromatin, affect DNA accessibility and regulate the expression of corresponding genes. What's more, the degree of lactylation is inseparable from the spatialized lactate concentration, which builds a bridge between epigenetics and metabolic reprogramming. Here, we review the important role of lactate in energy reprogramming, summarize the latest finding of lactylation in tumorigenesis and try to explore therapeutic strategies in oncotherapy that can kill two birds with one stone.

Citing Articles

Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications.

Xie X, Liu W, Yuan Z, Chen H, Mao W Mol Cancer. 2025; 24(1):71.

PMID: 40057791 PMC: 11889836. DOI: 10.1186/s12943-025-02269-y.


The role of lactylation in tumor growth and cancer progression.

Al-Malsi K, Xie S, Cai Y, Mohammed N, Xie K, Lan T Front Oncol. 2025; 15:1516785.

PMID: 39968078 PMC: 11832377. DOI: 10.3389/fonc.2025.1516785.


Lactate and lactylation in cancer.

Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y Signal Transduct Target Ther. 2025; 10(1):38.

PMID: 39934144 PMC: 11814237. DOI: 10.1038/s41392-024-02082-x.


Lactate-induced protein lactylation in cancer: functions, biomarkers and immunotherapy strategies.

Wang W, Wang H, Wang Q, Yu X, Ouyang L Front Immunol. 2025; 15:1513047.

PMID: 39867891 PMC: 11757118. DOI: 10.3389/fimmu.2024.1513047.


A Narrative Review of Prognostic Gene Signatures in Oral Squamous Cell Carcinoma Using LASSO Cox Regression.

Mohd Faizal N, Shai S, Savaliya B, Karen-Ng L, Kumari R, Kumar R Biomedicines. 2025; 13(1).

PMID: 39857718 PMC: 11759772. DOI: 10.3390/biomedicines13010134.


References
1.
Pan M, Reid M, Lowman X, Kulkarni R, Tran T, Liu X . Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation. Nat Cell Biol. 2016; 18(10):1090-101. PMC: 5536113. DOI: 10.1038/ncb3410. View

2.
Wang J, Liu Z, Xu Y, Wang Y, Wang F, Zhang Q . Enterobacterial LPS-inducible LINC00152 is regulated by histone lactylation and promotes cancer cells invasion and migration. Front Cell Infect Microbiol. 2022; 12:913815. PMC: 9359126. DOI: 10.3389/fcimb.2022.913815. View

3.
Pan L, Feng F, Wu J, Fan S, Han J, Wang S . Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells. Pharmacol Res. 2022; 181:106270. DOI: 10.1016/j.phrs.2022.106270. View

4.
Baylin S, Jones P . A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 2011; 11(10):726-34. PMC: 3307543. DOI: 10.1038/nrc3130. View

5.
Azad N, Zahnow C, Rudin C, Baylin S . The future of epigenetic therapy in solid tumours--lessons from the past. Nat Rev Clin Oncol. 2013; 10(5):256-66. PMC: 3730253. DOI: 10.1038/nrclinonc.2013.42. View